Safety profile of pharmacotherapy in paitionts with non-alcogolic fatty liver disease

Autor: E. I. Peresada, P. V. Seliverstov, T. V. Vavilova, V. A. Basharin, V. G. Radchenko
Jazyk: ruština
Rok vydání: 2019
Předmět:
Zdroj: Медицинский совет, Vol 0, Iss 3, Pp 69-75 (2019)
Druh dokumentu: article
ISSN: 2079-701X
2658-5790
DOI: 10.21518/2079-701X-2019-3-69-75
Popis: NAFLD is a leader among chronic liver diseases worldwide. Polymorbidity of such patients requires the appointment of different groups of drugs. The quality of pharmacological correction, which is determined in achieving the desired therapeutic effect and the absence of adverse reactions of the therapy, depends on the functional state of the liver. In diseases of the liver clearance of drugs is reduced, and the period of their half-life increases. Thus, drugs with high hepatic extraction may increase the risk of overdose. In this connection, prior to therapy, laboratory and instrumental control of liver function is necessary to reduce the risk of its drug damage, side effects of pharmacotherapy and prevention of complications.
Databáze: Directory of Open Access Journals